Header Logo

Connection

Gary Schaer to Female

This is a "connection" page, showing publications Gary Schaer has written about Female.
Connection Strength

0.310
  1. Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA? catheter mapping. Cardiovasc Revasc Med. 2018 12; 19(8S):50-52.
    View in: PubMed
    Score: 0.043
  2. Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction. Crit Pathw Cardiol. 2014 Jun; 13(2):62-5.
    View in: PubMed
    Score: 0.035
  3. Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series. Cardiovasc Radiat Med. 2004 Oct-Dec; 5(4):162-5.
    View in: PubMed
    Score: 0.018
  4. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.
    View in: PubMed
    Score: 0.017
  5. Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis. Catheter Cardiovasc Interv. 2003 Jun; 59(2):176-83.
    View in: PubMed
    Score: 0.016
  6. Predictors of late cardiac events following treatment with Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2003 Jan-Mar; 4(1):7-11.
    View in: PubMed
    Score: 0.016
  7. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018 06 14; 39(23):2208-2216.
    View in: PubMed
    Score: 0.012
  8. PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
    View in: PubMed
    Score: 0.010
  9. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
    View in: PubMed
    Score: 0.010
  10. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996 Aug 01; 94(3):298-307.
    View in: PubMed
    Score: 0.010
  11. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
    View in: PubMed
    Score: 0.010
  12. The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
    View in: PubMed
    Score: 0.010
  13. Impact of a novel interventional platform and hospital design on the door-to-balloon time in patients presenting with ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2015 Mar; 14(1):39-43.
    View in: PubMed
    Score: 0.009
  14. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J. 2013 Jun; 165(6):854-861.e2.
    View in: PubMed
    Score: 0.008
  15. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
    View in: PubMed
    Score: 0.008
  16. Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center experience. Crit Pathw Cardiol. 2012 Mar; 11(1):32-9.
    View in: PubMed
    Score: 0.007
  17. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
    View in: PubMed
    Score: 0.006
  18. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 08; 54(24):2277-86.
    View in: PubMed
    Score: 0.006
  19. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med. 1985 Jun; 13(6):492-6.
    View in: PubMed
    Score: 0.005
  20. Myocardial infarction after taking zolmitriptan. Yale J Biol Med. 2005 May; 78(3):147-50.
    View in: PubMed
    Score: 0.005
  21. Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol. 2005 Feb; 18(1):27-31.
    View in: PubMed
    Score: 0.005
  22. Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):109-12.
    View in: PubMed
    Score: 0.004
  23. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
    View in: PubMed
    Score: 0.004
  24. Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol. 2003 Aug 01; 92(3):312-4.
    View in: PubMed
    Score: 0.004
  25. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
    View in: PubMed
    Score: 0.004
  26. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002 Jan 02; 39(1):30-6.
    View in: PubMed
    Score: 0.004
  27. Clinical outcomes of patients treated with the cutting balloon and Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):12-5.
    View in: PubMed
    Score: 0.004
  28. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001 Aug 14; 104(7):779-82.
    View in: PubMed
    Score: 0.004
  29. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000 Nov 18; 356(9243):1705-10.
    View in: PubMed
    Score: 0.003
  30. Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
    View in: PubMed
    Score: 0.003
  31. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998 Jul 01; 82(1):43-9.
    View in: PubMed
    Score: 0.003
  32. Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
    View in: PubMed
    Score: 0.003
  33. Excimer laser ablation before autoperfusion balloon inflation: a novel therapeutic approach to high grade stenoses in vessels supplying substantial myocardium at risk. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):202-8.
    View in: PubMed
    Score: 0.002
  34. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol. 1983 Apr; 1(4):1154-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.